Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Suzawa; Toshiyuki
Address:
Yamato, JP
No. of patents:
9
Patents:












Patent Number Title Of Patent Date Issued
7547675 Chemically modified polypeptides June 16, 2009
The present invention relates to a chemically modified polypeptide in which at least one of hydroxyl groups in the polypeptide molecule is modified with a polyalkylene glycol derivative; a method for producing the modified polypeptide; a method of treatment using the modified polypep
7291713 Branched polyalkylene glycols November 6, 2007
The present invention provides a branched polyalkylene glycol wherein three or more single-chain polyalkylene glycols and a group having reactivity with an amino acid side chain, the N-terminal amino group or the C-terminal carboxyl group in a polypeptide or a group convertible into
6642355 Endothelin-antagonizing peptide November 4, 2003
The invention relates to an endothelin antagonistic peptide of the formula (I):wherein represents Asn or Asp; B represents His or Lys; E represents Ala or Ser; G represents Ala or Pro; X represents X.sup.1 -Gly or ##STR1## and Y represents hydroxy, lower alkoxy, amino, #
6638509 Toxin conjugates October 28, 2003
The present invention relates to a toxin conjugate in which a residue derived from a compound having an affinity for a target cell is bound to a toxin through a spacer comprising polyalkylene glycol and dipeptide.
6583267 Chemically modified polypeptides June 24, 2003
The present invention relates to a chemically modified polypeptide in which at least one of hydroxyl groups in the polypeptide molecule is modified with a polyalkylene glycol derivative; a method for producing the modified polypeptide; a method of treatment using the modified polypeptide
6194195 Strains of streptomyces producing endothelin antagonistic peptides February 27, 2001
The invention relates to biologically pure cultures of Streptomyces sp. RE-701 (FERM BP-3624) and Streptomyces sp. RE-629 (FERM BP-4126) that produce endothelin antagonistic peptides.
6103236 Toxin conjugates August 15, 2000
The present invention relates to a toxin conjugate in which a residue derived from a compound having an affinity for a target cell is bound to a toxin through a spacer comprising polyalkylene glycol and dipeptide.
5639860 Endothelin-antagonizing peptide June 17, 1997
Peptides represented by the following formula (I): ##STR1## wherein A represents Asn or Asp; B represents His or Lys; and E represents Ala or Ser;(1) X.sup.1 and Y.sup.1 are combined together to form a single bond as X.sup.1 --Y1, or (2) X.sup.1 represents hydrogen and Y.sup.1 repres
5631222 Endothelin-antagonizing peptide May 20, 1997
Disclosed is a peptide compound represented by the following formula (I):wherein R.sup.1-12, R.sup.14-18, and R.sup.20 are as defined in the specification.










 
 
  Recently Added Patents
Self-assembled, micropatterned, and radio frequency (RF) shielded biocontainers and their uses for remote spatially controlled chemical delivery
Deadline-driven parallel execution of queries
HYR1 as a target for active and passive immunization against Candida
Secure provisioning of a portable device using a representation of a key
Assisting apparatus, method, and program for checking crosstalk noise between hierarchized modules in a semiconductor circuit
Non-volatile memory and method having efficient on-chip block-copying with controlled error rate
System for implementing dynamic pseudorandom keyboard remapping
  Randomly Featured Patents
Controller and method for using a DC-DC converter in a mobile handset
Water release valve
Quiet water valve
Coulometric measuring method
Drag attachment for a disk
Porous absorbent and ink jet recording apparatus
Pipeline pig for lining pipe lines
Portable traction device
Virtual USB card reader with PCI express interface
Method of inhibiting binding of von Willebrand factor to human platelets and inducing interaction of platelets with vessel walls